Vyxeos is an intravenous (iv) chemotherapy used for the treatment of adults and pediatric patients 1 year and older with certain types of newly-diagnosed secondary acute myeloid leukemia (saml): Vyxeos should not be given to patients who have a history of serious allergic reaction to daunorubicin, cytarabine, or any of its ingredients.